SCIENTIFIC References
The company is not endorsed by, sponsored by, or affiliated with any of these organizations
1.King R, et al. GLP-1 Litigation Document on Gastroparesis Label Preemption. Robert King Law Firm. 2024. Available from https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/glp1-itigation-gastroparesis-label-preemption-order-.pdf
2.Akkermansia and Weight Loss. Front Nutr. 2024. doi: 10.1007/s11274-024-04012-z. Available from: https://link.springer.com/article/10.1007/s11274-024-04012-z
3.Journal of Diabetes, Obesity, and Metabolism. Study on Weight Rebound After Stopping GLP-1. 2024. doi: 10.1111/dom.14725. Available from: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14725
4.Habener J. Research on GLP-1 by Joel Habener. Harvard Medical School. 2024. Available from: https://hms.harvard.edu/news/harvard-medical-school-researcher-wins-2024-lasker-award-work-led-glp-1-therapies
5.GLP-1 and Obesity Link. ScienceDaily. 2015 Feb 26. Available from: https://www.sciencedaily.com/releases/2015/02/150226132056.htm
6.PFAS Chemicals and Weight Gain. Harvard School of Public Health. 2024. Available from: https://www.hsph.harvard.edu/news/press-releases/pfass-chemicals-environment-body-weight/